Demonstrates improved glycemic control with once-weekly insulins in type 2 diabetes, suggesting a new treatment approach.
Despite the availability of highly effective non-insulin glucose-lowering therapies, a substantial proportion of individuals with T2D ultimately require basal insulin to achieve and maintain gly...
No takes yet. Share an insight, caveat, or question.
Anaraki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: